Retatrutide is a new weight management drug injected weekly just under the skin (subcutaneous)
NHS access began in specialist weight management services from June 2025 for the highest-need patients, with tirzepatide prescribing incorporated into the GP Quality and Outcomes Framework from April 2026
This improvement in elasticity helps the skin bounce back from facial expressions, reducing the likelihood of new lines and wrinkles forming from repeated muscle movements
Check for blood before injecting the medicine
These bespoke infusions are delivered by trained medical professionals, ensuring both safety and efficacy a crucial factor behind their rising popularity in London, Knightsbridge, Chelsea, Kensington, Mayfair, Marylebone, and Belgravia